Co-occurring genomic alterations in non-small-cell lung cancer

Common genomic alterations recommended for inclusion in a

Efficacy and immune modulation of KRAS G12C inhibitor sotor…

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. - Abstract - Europe PMC

Genomic alterations and possible druggable mutations in carcinoma

Variation in targetable genomic alterations in non-small cell lung

Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes

Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer

IJMS, Free Full-Text

Co-occurring alterations in the RAS-MAPK pathway limit response to

JCM, Free Full-Text

Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer - ScienceDirect

Immunogenomic profiling of lung adenocarcinoma reveals high-grade growth patterns are associated with an immunogenic tumor microenvironment

Toward personalized treatment approaches for non-small-cell lung

Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity